Collectively, these findings suggest that tumor FoxP3 expression has a better prognostic potential in NSCLC and that, in combination with intratumoral Tregs, the absence of the tumor FoxP3 is correlated with high-risk patients. This evidence concerns the gene FOXP3 and neoplasm.